Printer Friendly

Vanda Pharmaceuticals names new senior vice president, general counsel and secretary.

M2 EQUITYBITES-August 14, 2018-Vanda Pharmaceuticals names new senior vice president, general counsel and secretary


Vanda Pharmaceuticals Incorporated (Nasdaq: VNDA), a global biopharmaceutical company, announced yesterday that it has named Timothy Williams as its new senior vice president, general counsel and secretary.

Prior to joining Vanda, Williams served as executive vice president, general counsel, chief compliance officer and corporate secretary at AgNovos Healthcare. Prior to this position, he was senior legal counsel and assistant secretary at Stryker Corporation where he led the legal department's global M&A, corporate governance, and securities groups. Before joining Stryker, he practiced law in Chicago at Mayer Brown LLP and Bryan Cave LLP.

Mihael H Polymeropoulos, MD, president and CEO of Vanda, said, 'I am very pleased to welcome Tim to the Vanda executive management team. He is an exceptional leader and lawyer and brings a wealth of experience that we expect will prove instrumental as we continue to execute our global strategy.'

((Comments on this story may be sent to

COPYRIGHT 2018 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2018 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 EquityBites (EQB)
Date:Aug 14, 2018
Previous Article:Cumberland Pharmaceuticals names new senior director, clinical and regulatory affairs.
Next Article:The US Food and Drug Administration approves Alnylam Pharmaceuticals' Onpattro.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters